.8 billion on psychedelic drugs for mental health. Paper in Nature Reviews. Drug Discovery, 1 Sep 2026." /> .8 billion on psychedelic drugs for mental health · Science library · PsyDAO" /> .8 billion on psychedelic drugs for mental health. Paper in Nature Reviews. Drug Discovery, 1 Sep 2026." /> .8 billion on psychedelic drugs for mental health · Science library · PsyDAO" /> .8 billion on psychedelic drugs for mental health. Paper in Nature Reviews. Drug Discovery, 1 Sep 2026." />

Lilly spends US$2.8 billion on psychedelic drugs for mental health

Paper. Mullard A. Nature Reviews. Drug Discovery, 1 Sep 2026.

Weekly Science Digest, 20 Jul 2026 to 2 Oct 2026, finding 12: Big Pharma and the FDA move

Eli Lilly agreed in July to acquire AtaiBeckley for $2.8 billion. In September, FDA officials set out the agency's updated framework for developing psychedelic drugs in the New England Journal of Medicine, building on its 2023 draft guidance.

How much weight it carries: News and policy, not research findings. (Industry, Policy)

Read the original

—
Node—
Statuslive
Throughput—